Radaeva Svetlana, Sun Rui, Jaruga Barbara, Nguyen Van T, Tian Zhigang, Gao Bin
Section on Liver Biology, Laboratory of Physiologic Studies, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland 20892, USA.
Gastroenterology. 2006 Feb;130(2):435-52. doi: 10.1053/j.gastro.2005.10.055.
BACKGROUND & AIMS: Viral hepatitis infection, which is a major cause of liver fibrosis, is associated with activation of innate immunity. However, the role of innate immunity in liver fibrosis remains obscure.
Liver fibrosis was induced either by feeding mice with the 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) diet or by injecting them with carbon tetrachloride. The Toll-like receptor 3 ligand, polyinosinic-polycytidylic acid, was used to activate innate immunity cells and mediators, including natural killer cells and interferon gamma.
In the mouse model of DDC-induced liver fibrosis, natural killer cell activation by polyinosinic-polycytidylic acid induced cell death to activated hepatic stellate cells and attenuated the severity of liver fibrosis. Polyinosinic-polycytidylic acid treatment also ameliorated liver fibrosis induced by carbon tetrachloride. The observed protective effect of polyinosinic-polycytidylic acid on liver fibrosis was diminished through either depletion of natural killer cells or by disruption of the interferon gamma gene. Expression of retinoic acid early inducible 1, the NKG2D ligand, was undetectable on quiescent hepatic stellate cells, whereas high levels were found on activated hepatic stellate cells, which correlated with the resistance and susceptibility of quiescent hepatic stellate cells and activated hepatic stellate cells to natural killer cell lysis, respectively. Moreover, treatment with polyinosinic-polycytidylic acid or interferon gamma enhanced the cytotoxicity of natural killer cells against activated hepatic stellate cells and increased the expression of NKG2D and tumor necrosis factor-related apoptosis-inducing ligand on liver natural killer cells. Blocking NKG2D or tumor necrosis factor-related apoptosis-inducing ligand with neutralizing antibodies markedly diminished the cytotoxicity of polyinosinic-polycytidylic acid-activated natural killer cells against activated hepatic stellate cells.
Our findings suggest that natural killer cells kill activated hepatic stellate cells via retinoic acid early inducible 1/NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent mechanisms, thereby ameliorating liver fibrosis.
病毒性肝炎感染是肝纤维化的主要原因,与先天免疫激活有关。然而,先天免疫在肝纤维化中的作用仍不清楚。
通过给小鼠喂食3,5 - 二乙氧羰基 - 1,4 - 二氢可力丁(DDC)饮食或注射四氯化碳诱导肝纤维化。使用Toll样受体3配体聚肌苷酸 - 聚胞苷酸激活先天免疫细胞和介质,包括自然杀伤细胞和干扰素γ。
在DDC诱导的肝纤维化小鼠模型中,聚肌苷酸 - 聚胞苷酸激活自然杀伤细胞可诱导活化的肝星状细胞死亡,并减轻肝纤维化的严重程度。聚肌苷酸 - 聚胞苷酸治疗还改善了四氯化碳诱导的肝纤维化。通过自然杀伤细胞耗竭或干扰素γ基因破坏,聚肌苷酸 - 聚胞苷酸对肝纤维化的保护作用减弱。视黄酸早期诱导物1(NKG2D配体)在静止肝星状细胞上未检测到表达,而在活化的肝星状细胞上发现高水平表达,这分别与静止肝星状细胞和活化肝星状细胞对自然杀伤细胞裂解的抗性和敏感性相关。此外,聚肌苷酸 - 聚胞苷酸或干扰素γ处理增强了自然杀伤细胞对活化肝星状细胞的细胞毒性,并增加了肝脏自然杀伤细胞上NKG2D和肿瘤坏死因子相关凋亡诱导配体的表达。用中和抗体阻断NKG2D或肿瘤坏死因子相关凋亡诱导配体可显著降低聚肌苷酸 - 聚胞苷酸激活的自然杀伤细胞对活化肝星状细胞 的细胞毒性。
我们的研究结果表明,自然杀伤细胞通过视黄酸早期诱导物1/NKG2D依赖性和肿瘤坏死因子相关凋亡诱导配体依赖性机制杀死活化的肝星状细胞,从而改善肝纤维化。